An epidemic of Pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia

Transplant Proc. 2012 Nov;44(9):2818-20. doi: 10.1016/j.transproceed.2012.09.089.

Abstract

Although only 2 cases of Pneumocystis jiroveci pneumonia were observed in our center between 2004 and 2009, we diagnosed 9 cases in 2010. Each patient had been in contact in the hospital with at least 1 other patient suffering P jiroveci pneumonia. Genotyping of P jiroveci pneumonia strains demonstrates a total homogeneity of the DNA sequences in the 7 patients already analyzed. CD4+ lymphocyte count was significantly lower at M3 in P jiroveci pneumonia patients than in controls. Our clinical and molecular data confirm that interhuman transmission of P jiroveci is possible, particularly to lymphopenic transplant recipients.

MeSH terms

  • CD4 Lymphocyte Count
  • Chi-Square Distribution
  • Cross Infection / epidemiology*
  • Cross Infection / immunology
  • Cross Infection / microbiology
  • Cross Infection / therapy
  • Cross Infection / transmission
  • Epidemics*
  • France / epidemiology
  • Genotype
  • Humans
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / immunology*
  • Lymphopenia / immunology*
  • Pneumocystis carinii / genetics
  • Pneumocystis carinii / pathogenicity*
  • Pneumonia, Pneumocystis / epidemiology*
  • Pneumonia, Pneumocystis / immunology
  • Pneumonia, Pneumocystis / microbiology
  • Pneumonia, Pneumocystis / therapy
  • Pneumonia, Pneumocystis / transmission
  • Retrospective Studies
  • Risk Factors
  • T-Lymphocytes / immunology*
  • Time Factors